BSEInsider Trading / SASTPromoter Reclassif.2d ago
Trident Texofab Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
Hardik Desai Family Trust has made a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a change in promoter holding in Trident Texofab Ltd.
BSECompany UpdateResults4d ago
Trident Texofab Ltd
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on 12th August, ....
Trident Texofab Ltd has published a newspaper advertisement regarding the extract of the Un-Audited Standalone Financial Results for the quarter ended June 30,2026. The results are available on the company's website.
BSECompany UpdateAuditor Change6d ago
Trident Texofab Ltd
The Board took on record Resignation of M/s. Shah Kailash and Associates LLP, Chartered Accountant, FRN: 109647W as Statutory Auditor of the Company with effect from 10th August, 2026
Trident Texofab Ltd has announced the resignation of its statutory auditor, M/s. Shah Kailash and Associates LLP, effective August 10, 2026. The company has also announced the appointment of M/s. Priti Agrawal & Co. as its internal auditor for the financial year 2026-27. Additionally, the company has released unaudited financial results for the quarter ended June 30, 2026.
BSECompany UpdateResults6d ago
Trident Texofab Ltd
The Board of Directors inter-alia has approved the Appointment of M/s. Prit Agrawal & CO., Chartered Accountant having FRN No. 152249W as an Internal Auditor for the financial year 2026-27.
Trident Texofab Ltd has announced the appointment of M/s. Prit Agrawal & Co. as an internal auditor for the financial year 2026-27. The company has also disclosed unaudited financial results for the quarter ended June 30, 2026, along with a limited review report by the statutory auditor. The results show a profit of Rs. 52.18 crore for the quarter, with a net profit of Rs. 70.16 crore for the period.
BSEResult▼ NegativeResults6d ago
Trident Texofab Ltd
Un-Audited Financial Results for the quarter ended on June 30, 2026 along with Limited Review Report on said results by the Statutory Auditor of the Company
Trident Texofab Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,614.26 crore, a decline of 22.3% from ₹3,357.02 crore in the same quarter last year. The company has also reported a net loss of ₹200.94 crore for the quarter, compared to a net profit of ₹101.59 crore in the same quarter last year.
BSEBoard Meeting▼ NegativeResults6d ago
Trident Texofab Ltd
Outcome of Board Meeting held on 10.08.2026
Trident Texofab Ltd announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,614.26 crore, a decrease of 21.5% from ₹3,357.02 crore in the same quarter last year. The company reported a net loss of ₹200.94 crore, compared to a net profit of ₹101.59 crore in the same quarter last year. The board of directors approved the appointment of M/s. Priti Agrawal & Co. as the internal auditor for the financial year 2026-27.